Moderna plans to begin its final phase of testing for the COVID-19 vaccine on July 27

Change language:

The Cambridge, Massachusetts-based biotech company is the first to announce a start date for phase 3 study in the United States.

The study aims to valuate the efficacy, safety, and immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in adults aged 18 years and older, according to information on the website, which is maintained by the U.S. National Library of Medicine of the National Institutes of Health.

Researchers plan to enroll 30,000 adult participants, including people whose locations or circumstances put them at high-risk of infection. Participants will either receive the vaccine or a placebo.

The experimental group will be injected with 100 micrograms of the vaccine on day one and again on day 29. The placebo group will be injected with two doses of matching placebo on the same dates.

Researchers will evaluate whether the participants develop COVID-19 14 days after they get their second dose.

Continue reading

One comment

  1. If anyone takes this vaccine they are taking the Biblical Mark of the Beast from the Book of Revelations in The Holy Bible. This vaccine will not only alter your DNA it will set you apart from The Creator and make you trackable with the Nano tracking devices contained with in it with 5G technology. You will no longer be able to enter The Kingdom of Heaven. You will spend eternity in Hell. DO NOT allow ANYONE to inject you with this vaccine. Better to die from CV19 than spend eternity in the lake of fire.

Leave a Reply

Your email address will not be published. Required fields are marked *